Canada Biotechnology & Medical Research

Oncolytics Biotech Inc (ONC)

Track

Oncolytics Biotech Inc. experienced significant insider buying activity during February and March 2026. Multiple executives and directors, including the CEO, acquired shares through open market purchases. The most recent transactions occurred on March 12, 2026, reflecting a consistent pattern of accumulation by leadership throughout this period.
Ticker: ONC Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Oncolytics Biotech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Kelly, Jared Ryan Senior Officer of Issuer Officer
Transaction date
Purchase
Price
39.78
Quantity 87,692 -19.5%
Value US$4,001,854
Kelly Jared Chief Executive Officer Executive Director
Transaction date
Purchase
Price
415.78
Quantity 59,706 +17.9%
Value US$884,447
Parsons, James Todd Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
204.66
Quantity 79,571 +49.4%
Value US$2,612,661
Parsons James T. Non-Executive Director
Transaction date
Purchase
Price
1.03
Quantity 10,000 +31.4%
Value US$10,300
0.6
Seizinger, Bernd Robert Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.85
Quantity 40,000 +7.6%
Value US$33,864
Pisano, Wayne Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.84
Quantity 30,000 +11.6%
Value US$25,338
Look, Kirk Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.84
Quantity 12,000 +7.5%
Value US$10,104
Kelly, Jared Ryan Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.84
Quantity 29,500 +37.1%
Value US$24,839
Heineman, Thomas Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.83
Quantity 12,132 +7.8%
Value US$10,033
Hagerman, Allison Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.83
Quantity 10,000 +14.3%
Value US$8,298
Brown, Deborah Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.85
Quantity 25,000 +29.5%
Value US$21,240
Andrews, Patricia Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.86
Quantity 35,400 +82.8%
Value US$30,292
Look Kirk Chief Financial Officer Officer
Transaction date
Purchase
Price
0.84
Quantity 12,000 +4.4%
Value US$10,104
Kelly Jared Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.84
Quantity 29,500 +37.1%
Value US$24,839
0.5
Andrews Patricia S Non-Executive Director
Transaction date
Purchase
Price
0.86
Quantity 35,400 +82.8%
Value US$30,292
Heineman Thomas Charles Chief Medical Officer Officer
Transaction date
Purchase
Price
0.83
Quantity 12,132 +4.5%
Value US$10,033
2.9
Seizinger Bernd R. Non-Executive Director
Transaction date
Purchase
Price
0.85
Quantity 40,000 +7.6%
Value US$33,864
3.0
Pisano Wayne Non-Executive Director
Transaction date
Purchase
Price
0.84
Quantity 30,000 +6.5%
Value US$25,338
Hagerman Allison VP, Product Development Officer
Transaction date
Purchase
Price
0.83
Quantity 10,000 +9.5%
Value US$8,298
Brown Deborah Margaret Non-Executive Director
Transaction date
Purchase
Price
0.85
Quantity 25,000 +29.5%
Value US$21,240
0.6
Seizinger, Bernd Robert Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
0.83
Quantity 60,000 +12.8%
Value US$49,590
Kelly, Jared Ryan Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.84
Quantity 5,600 +7.6%
Value US$4,682
Aromando, Andrew P. Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.86
Quantity 29,600 +116.1%
Value US$25,418
Aromando Andrew Chief Business Officer Officer
Transaction date
Purchase
Price
0.86
Quantity 29,600 +116.1%
Value US$25,418
Kelly Jared Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.84
Quantity 5,600 +7.6%
Value US$4,682
2.9
Seizinger Bernd R. Non-Executive Director
Transaction date
Purchase
Price
0.83
Quantity 60,000 +12.8%
Value US$49,590
0.6
Seizinger, Bernd Robert Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 100,000 +27.2%
Value US$103,770
2.9
Seizinger Bernd R. Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 100,000 +27.2%
Value US$103,770
Kelly, Jared Ryan Senior Officer of Issuer Officer
Transaction date
Purchase
Price
0.86
Quantity 23,500 +46.6%
Value US$20,280
Heineman, Thomas Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.27
Quantity 15,000 +11.3%
Value US$19,050
Hagerman, Allison Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.71
Quantity 4,600 +7.3%
Value CA$7,866
Kelly, Jared Ryan Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.19
Quantity 50,400
Value US$60,062
Look, Kirk Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.17
Quantity 12,800 +9.3%
Value US$14,976
Aromando, Andrew P. Senior Officer of Issuer Officer
Transaction date
Purchase
Price
1.19
Quantity 25,500
Value US$30,238
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-12 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
87,692 -19.5%
39.78
US$4,001,854 		87,692 -19.5% 39.78 US$4,001,854
2026-03-13 2026-03-12 B Purchase
Kelly Jared

Chief Executive Officer

Executive Director
59,706 +17.9%
415.78
US$884,447 		59,706 +17.9% 415.78 US$884,447
2026-03-13 2026-03-11 B Purchase
Parsons, James Todd

Director of Issuer

Non-Executive Director
79,571 +49.4%
204.66
US$2,612,661 		79,571 +49.4% 204.66 US$2,612,661
2026-03-13 2026-03-11 B Purchase
Parsons James T.
Non-Executive Director
10,000 +31.4%
1.03
US$10,300 		10,000 +31.4% 1.03 US$10,300
2026-02-13 2026-02-12 B Purchase
0.6
Seizinger, Bernd Robert

Director of Issuer

Non-Executive Director
40,000 +7.6%
0.85
US$33,864 		40,000 +7.6% 0.85 US$33,864
2026-02-13 2026-02-12 B Purchase
Pisano, Wayne

Director of Issuer

Non-Executive Director
30,000 +11.6%
0.84
US$25,338 		30,000 +11.6% 0.84 US$25,338
2026-02-13 2026-02-12 B Purchase
Look, Kirk

Senior Officer of Issuer

Officer
12,000 +7.5%
0.84
US$10,104 		12,000 +7.5% 0.84 US$10,104
2026-02-13 2026-02-12 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
29,500 +37.1%
0.84
US$24,839 		29,500 +37.1% 0.84 US$24,839
2026-02-13 2026-02-12 B Purchase
Heineman, Thomas

Senior Officer of Issuer

Officer
12,132 +7.8%
0.83
US$10,033 		12,132 +7.8% 0.83 US$10,033
2026-02-13 2026-02-12 B Purchase
Hagerman, Allison

Senior Officer of Issuer

Officer
10,000 +14.3%
0.83
US$8,298 		10,000 +14.3% 0.83 US$8,298
2026-02-13 2026-02-12 B Purchase
Brown, Deborah

Director of Issuer

Non-Executive Director
25,000 +29.5%
0.85
US$21,240 		25,000 +29.5% 0.85 US$21,240
2026-02-13 2026-02-12 B Purchase
Andrews, Patricia

Director of Issuer

Non-Executive Director
35,400 +82.8%
0.86
US$30,292 		35,400 +82.8% 0.86 US$30,292
2026-02-13 2026-02-12 B Purchase
Look Kirk

Chief Financial Officer

Officer
12,000 +4.4%
0.84
US$10,104 		12,000 +4.4% 0.84 US$10,104
2026-02-13 2026-02-12 B Purchase
Kelly Jared

Chief Executive Officer

Executive Director
29,500 +37.1%
0.84
US$24,839 		29,500 +37.1% 0.84 US$24,839
2026-02-13 2026-02-12 B Purchase
0.5
Andrews Patricia S
Non-Executive Director
35,400 +82.8%
0.86
US$30,292 		35,400 +82.8% 0.86 US$30,292
2026-02-13 2026-02-12 B Purchase
Heineman Thomas Charles

Chief Medical Officer

Officer
12,132 +4.5%
0.83
US$10,033 		12,132 +4.5% 0.83 US$10,033
2026-02-13 2026-02-12 B Purchase
2.9
Seizinger Bernd R.
Non-Executive Director
40,000 +7.6%
0.85
US$33,864 		40,000 +7.6% 0.85 US$33,864
2026-02-13 2026-02-12 B Purchase
3.0
Pisano Wayne
Non-Executive Director
30,000 +6.5%
0.84
US$25,338 		30,000 +6.5% 0.84 US$25,338
2026-02-13 2026-02-12 B Purchase
Hagerman Allison

VP, Product Development

Officer
10,000 +9.5%
0.83
US$8,298 		10,000 +9.5% 0.83 US$8,298
2026-02-13 2026-02-12 B Purchase
Brown Deborah Margaret
Non-Executive Director
25,000 +29.5%
0.85
US$21,240 		25,000 +29.5% 0.85 US$21,240
2026-02-13 2026-02-11 B Purchase
0.6
Seizinger, Bernd Robert

Director of Issuer

Non-Executive Director
60,000 +12.8%
0.83
US$49,590 		60,000 +12.8% 0.83 US$49,590
2026-02-13 2026-02-11 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
5,600 +7.6%
0.84
US$4,682 		5,600 +7.6% 0.84 US$4,682
2026-02-13 2026-02-11 B Purchase
Aromando, Andrew P.

Senior Officer of Issuer

Officer
29,600 +116.1%
0.86
US$25,418 		29,600 +116.1% 0.86 US$25,418
2026-02-13 2026-02-11 B Purchase
Aromando Andrew

Chief Business Officer

Officer
29,600 +116.1%
0.86
US$25,418 		29,600 +116.1% 0.86 US$25,418
2026-02-13 2026-02-11 B Purchase
Kelly Jared

Chief Executive Officer

Executive Director
5,600 +7.6%
0.84
US$4,682 		5,600 +7.6% 0.84 US$4,682
2026-02-13 2026-02-11 B Purchase
2.9
Seizinger Bernd R.
Non-Executive Director
60,000 +12.8%
0.83
US$49,590 		60,000 +12.8% 0.83 US$49,590
2026-01-20 2026-01-16 B Purchase
0.6
Seizinger, Bernd Robert

Director of Issuer

Non-Executive Director
100,000 +27.2%
1.04
US$103,770 		100,000 +27.2% 1.04 US$103,770
2026-01-20 2026-01-16 B Purchase
2.9
Seizinger Bernd R.
Non-Executive Director
100,000 +27.2%
1.04
US$103,770 		100,000 +27.2% 1.04 US$103,770
2025-08-12 2025-08-12 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
23,500 +46.6%
0.86
US$20,280 		23,500 +46.6% 0.86 US$20,280
2025-07-18 2025-07-17 B Purchase
Heineman, Thomas

Senior Officer of Issuer

Officer
15,000 +11.3%
1.27
US$19,050 		15,000 +11.3% 1.27 US$19,050
2025-07-18 2025-07-17 B Purchase
Hagerman, Allison

Senior Officer of Issuer

Officer
4,600 +7.3%
1.71
CA$7,866 		4,600 +7.3% 1.71 CA$7,866
2025-07-17 2025-07-16 B Purchase
Kelly, Jared Ryan

Senior Officer of Issuer

Officer
50,400
1.19
US$60,062 		50,400 1.19 US$60,062
2025-07-17 2025-07-15 B Purchase
Look, Kirk

Senior Officer of Issuer

Officer
12,800 +9.3%
1.17
US$14,976 		12,800 +9.3% 1.17 US$14,976
2025-07-17 2025-07-15 B Purchase
Aromando, Andrew P.

Senior Officer of Issuer

Officer
25,500
1.19
US$30,238 		25,500 1.19 US$30,238
Explore more

More insider trading research around Oncolytics Biotech Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America